NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/17/2024
Back to search
Official data from USPTO
PHARMINTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
10/17/2024
Classification
Registered
Trademark type
Word
Nice classes
35
Filing date
08/12/2002
Registration date
08/03/2004
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2024
Last transaction
10/17/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
99
Owner location
BOLOGNA (BO), IT
Examiner
CLAYTON, CHERYL A
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PHARMINTECH S.R.L.
IPACK-IMA S.P.A.
IPACK-IMA S.r.l.
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
ORGANIZING EXHIBITIONSMEETINGSTRADESHOWSJOB FAIRS IN THE FIELD OF PHARMACEUTICAL AND PARAPHARMACEUTICAL INDUSTRY
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/17/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
07/24/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/03/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/13/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/13/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/13/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/13/2014
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/30/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
07/25/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/20/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/20/2010
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/04/2010
E815
TEAS SECTION 8 & 15 RECEIVED
07/30/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
08/03/2004
1.BD
Sec. 1(B) CLAIM DELETED
05/21/2004
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/21/2004
PAPER RECEIVED
05/21/2004
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/23/2004
PUBO
PUBLISHED FOR OPPOSITION
12/30/2003
NPUB
NOTICE OF PUBLICATION
12/10/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2003
PAPER RECEIVED
09/23/2003
GNSL
LETTER OF SUSPENSION E-MAILED
08/26/2003
CFIT
CASE FILE IN TICRS
07/18/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2003
PAPER RECEIVED
07/03/2003
GNRT
NON-FINAL ACTION E-MAILED
01/21/2003
DOCK
ASSIGNED TO EXAMINER
01/14/2003
PAPER RECEIVED
11/29/2002
PAPER RECEIVED
11/26/2002
Continuous trademark protection
Get notified about every new filing that threatens PHARMINTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.